| 产品编号 | bs-46007P |
| 英文名称 | Recombinant SARS-Cov-2 Spike protein, Fc & Avi (HEK293) |
| 中文名称 | 重组SARS冠状病毒2 Spike S 蛋白 |
| 别 名 | Recombinant SARS-Cov-2 Spike protein, Fc & Avi (HEK293) 新冠病毒S蛋白; 新冠S蛋白; SARS-CoV-2 S蛋白; |
 |
Specific References (2) | bs-46007P has been referenced in 2 publications.
[IF=4.225] Acharya Balkrishna. et al. Giloy Ghanvati (Tinospora cordifolia (Willd.) Hook. f. and Thomson) Reversed SARS-CoV-2 Viral Spike-Protein Induced Disease Phenotype in the Xenotransplant Model of Humanized Zebrafish. Front Pharmacol. 2021; 12: 635510 Other ;
[IF=3.267] Acharya Balkrishna. et al. Application of Humanized Zebrafish Model in the Suppression of SARS-CoV-2 Spike Protein Induced Pathology by Tri-Herbal Medicine Coronil via Cytokine Modulation. Molecules. 2020 Jan;25(21):5091
|
| 理论分子量 | 160kDa |
| 检测分子量 | 110-130 kDa |
| 性 状 | Lyophilized or Liquid |
| 浓 度 | ＞0.5 mg/ml |
| 物 种 | SARS-Cov-2 |
| 序 列 | 14-1212/1273 |
| 纯 度 | >95% as determined by SDS-PAGE |
| 纯化方法 | AC |
| 内毒素 | Not analyzed |
| 表达系统 | HEK293 cell |
| 活性 | Yes |
| 标签 | Fc & Avi |
| 缓 冲 液 | Lyophilized from 0.22 um filtered solution in 2X PBS (pH=7.4). Normally 5% trehalose is added as protectant before lyophilization. |
| 保存条件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 产品介绍 |
The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. SWISS: P0DTC2 Gene ID: 43740568 |
| 产品图片 |
The purity of the protein is greater than 80% as determined by reducing SDS-PAGE.
|
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
